Trials / Sponsors / Rise Therapeutics LLC
Rise Therapeutics LLC
Industry · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderat COPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbation, COPD Exacerbation Acute | Phase 1 | 2026-09-01 |
| Not Yet Recruiting | R-2487 in Patients With Sjogren's Syndrome (SS) Sjogren's Syndrome, Sjögren, Sjögren Syndrome, Unspecified | Phase 1 | 2026-06-01 |
| Recruiting | R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) i Solid Tumor, Adult, Solid Tumor, Melanoma | Phase 1 | 2025-08-01 |
| Completed | R-5280 in Newly Diagnosed Patients With Type 1 Diabetes Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes Mellitus, Type 1 | Phase 1 | 2023-12-05 |
| Recruiting | R-2487 in Patients With Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 1 | 2023-10-19 |
| Recruiting | R-3750 in Patients With Mild to Moderate Ulcerative Colitis Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic | Phase 1 | 2023-02-27 |